Literature DB >> 12235743

[Predictive value of changes in the hemostasis system in patients with ischemic brain diseases].

Ranko Raicević1, Aco Jovicić, Slavka Mandić-Radić, Dragana Dordević, Bratisłav Magdić, Ljubo Marković, Dragana Veljancić, Evica Dincić, Slobodan Obradović.   

Abstract

The aim of this research was to determine the importance of tracking the dynamics of changes of the hemostatic system factors (aggregation of thrombocytes, D-dimer, PAI-1, antithrombin III, protein C and protein S, factor VII and factor VIII, fibrin degradation products, euglobulin test and th activated partial thromboplastin time--aPTPV) in relation to the level of the severity of ischaemic brain disorders (IBD) and the level of neurological and functional deficiency in the beginning of IBD manifestation from 7 to 10 days, 19 to 21 day, and after 3 to 6 months. The research results confirmed significant predictive value of changes of hemostatic system with the predomination of procoagulant factors, together with the insufficiency of fibrinolisys. Concerning the IBD severity and it's outcome, the significant predictive value was shown in the higher levels of PAI-1 and the lower level of antithrombin III, and borderline significant value was shown in the accelerated aggregation of thrombocytes and the increased concentration of D-dimer. It could be concluded that the tracking of the dynamics of changes in parameters of hemostatic system proved to be an easily accessible method with the significant predictive value regarding the development of more severe. IBD cases and the outcome of the disease itself.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235743     DOI: 10.2298/vsp0204377r

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  1 in total

1.  Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Authors:  Leonardo Lorente; María M Martín; Luis Ramos; Juan J Cáceres; Jordi Solé-Violán; Mónica Argueso; Alejandro Jiménez; Juan M Borreguero-León; Josune Orbe; José A Rodríguez; José A Páramo
Journal:  BMC Neurol       Date:  2015-07-11       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.